MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect

Oncogene

Volumn 34, Issue 21, 2015, Pages 2700-2710

  Lin, L ^a   Huang, H ^a   Liao, W ^a   Ma, H ^a   Liu, J ^a   Wang, L ^a   Huang, N ^a   Liao, Y ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; DORSOMORPHIN; GLUCOSE TRANSPORTER 1; HEXOKINASE; LACTATE DEHYDROGENASE; MESSENGER RNA; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN; PROTEIN KINASE; PYRUVATE DEHYDROGENASE KINASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; MACC1 PROTEIN, HUMAN; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER SIZE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; MALE; METABOLIC STRESS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE MACC1; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; UPREGULATION; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETICS; GLYCOLYSIS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; METABOLISM; MIDDLE AGED; MITOCHONDRIA; STOMACH NEOPLASMS; STRESS, PHYSIOLOGICAL; UP-REGULATION; WALKER-WARBURG SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; STOMACH NEOPLASMS; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS; UP-REGULATION; WALKER-WARBURG SYNDROME;

EID: 84930272770     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.204     Document Type: Article

References (32)

1. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17: 1498-1503.
2. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011; 25: 717-729.
3. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 2009; 69: 4918-4925.
4. Kokoszynska K, Krynski J, Rychlewski L, Wyrwicz LS. Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 2009; 56: 317-323.
5. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-337.
6. Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012; 485: 661-665.
7. Keller KE, Tan IS, Lee YS. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 2012; 338: 1069-1072.
8. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325: 1555-1559.
9. Huber AL, Lebeau J, Guillaumot P, Petrilli V, Malek M, Chilloux J et al. p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose. Mol Cell 2013; 49: 1049-1059.
10. Gao M, Liang J, Lu Y, Guo H, German P, Bai S et al. Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene 2014; 33: 745-755.
11. Wu CA, Chao Y, Shiah SG, Lin WW. Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase. Biochim Biophys Acta 2013; 1833: 1147-1156.
12. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009; 15: 59-67.
13. Meng F, Li H, Shi H, Yang Q, Zhang F, Yang Y et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One 2013; 8: E60821.
14. Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 2013; 8: E64235.
15. Wang L, Wu Y, Lin L, Liu P, Huang H, Liao W et al. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer 2013; 133: 1419-1430.
16. Galimi F, Torti D, Sassi F, Isella C, Cora D, Gastaldi S et al. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: Response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 2011; 17: 3146-3156.
17. Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 2001; 98: 247-252.
18. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330: 1340-1344.
19. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703-707.
20. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: What is so special about them? Trends Cell Biol 2008; 18: 165-173.
21. Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev 2011; 25: 1041-1051.
22. Li G, Ci W, Karmakar S, Chen K, Dhar R, Fan Z et al. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell 2014; 25: 455-468.
23. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 2010; 107: 2037-2042.
24. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 2013; 23: 316-331.
25. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med 2011; 208: 313-326.
26. Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett 2012; 4: 783-791.
27. Zhao C, Yasumura D, Li X, Matthes M, Lloyd M, Nielsen G et al. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest 2011; 121: 369-383.
28. Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NPet al. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J; 2014 e-pub ahead of print May 2014; doi:2010.15252/embj.201488598.
29. Falck Miniotis M, Arunan V, Eykyn TR, Marais R, Workman P, Leach MO et al. MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells. Cancer Res 2013; 73: 4039-4049.
30. Mimeault M, Batra SK. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Mol Aspects Med; 2013 e-pub ahead of print August 2013; doi:2010.1016/j. mam.2013.2008.2001.
31. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
32. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11: 37-51.